University Hospital, Basel, Switzerland
Clinical trials sponsored by University Hospital, Basel, Switzerland, explained in plain language.
-
Blue dye could prevent wound problems after groin surgery
Disease control Not yet recruitingThis pilot study tests a simple method to reduce wound complications after groin vascular surgery. Surgeons will inject a blue dye into the skin around the surgical wound to make any lymphatic leaks visible, then repair them immediately. The study will enroll 60 adults and track …
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New CAR t therapy targets two proteins to fight blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR T cell therapy that targets two proteins (CD19 and CD20) on B cell cancer cells. It is for adults with B cell leukemia or lymphoma who have run out of standard options, including commercial CAR T cells. The main goal is to check safe…
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Village health workers lead new HIV prevention effort in lesotho
Prevention Not yet recruitingThis study tests a new program where trained village health workers use tablet-based tools to provide HIV prevention services, including PrEP and emergency PEP, to people at high risk in rural Lesotho. About 380 participants will be enrolled to see if this approach increases mont…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Can a common sedative stop ICU delirium in heavy drinkers?
Prevention Not yet recruitingThis study tests whether giving lorazepam, a sedative, can prevent delirium in intensive care patients who are at high risk due to heavy alcohol use. Researchers will use a blood test (Anttila-Index) to identify these patients. The trial involves 260 adults admitted to the ICU, w…
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New drug aims to stop EBV in kidney transplants
Prevention Not yet recruitingThis study tests whether an IDO-1 inhibitor can safely prevent Epstein-Barr virus (EBV) infection in kidney transplant recipients who have never had EBV but receive a kidney from an EBV-positive donor. Nine participants will receive either the drug or a placebo for 28 days, along…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
New study aims to bridge psychosocial care gap for cancer survivors
Knowledge-focused Not yet recruitingThis study tests whether a routine digital screening followed by a supportive phone call can help cancer survivors get the emotional and social support they need after finishing primary treatment. Fifty adults who have completed cancer therapy will take part. The goal is to see i…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could a 3-Step hand wash beat the standard 6-Step?
Knowledge-focused Not yet recruitingThis study compares a quick 3-step hand hygiene technique to the standard 6-step method recommended by the World Health Organization. Researchers want to see if the simpler method leads to better compliance among healthcare workers and still keeps hands clean. The trial will invo…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
SENSATION trial: can smelling and tasting your meal boost calorie burn?
Knowledge-focused Not yet recruitingThis study tests whether sensory stimulation—like tasting and smelling food—affects how much energy your body uses to digest a meal. Twenty-four healthy volunteers will eat the same meal in two ways: normally by mouth, and through a tube that bypasses the senses. Researchers will…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Ecstasy drug used to probe social brain in autism
Knowledge-focused Not yet recruitingThis study gives 40 adults—half with autism, half without—a single dose of MDMA (the active ingredient in ecstasy) or a placebo to see how it changes oxytocin levels in the blood. Oxytocin is often called the 'love hormone' and helps with social bonding. The goal is not to treat …
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a smart patch replace a pill for temperature monitoring?
Knowledge-focused Not yet recruitingThis small study with 12 adults checks if wearable temperature sensors can collect reliable data when compared to an ingestible capsule that measures core body temperature. Participants wear the sensors and swallow the capsule for about 48 hours. The goal is to see if the process…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Swiss ICU docs quizzed on ultrasound Know-How
Knowledge-focused Not yet recruitingThis study surveys 200 ICU doctors in Switzerland to understand how they use ultrasound to manage fluids and check for vein congestion. The goal is to learn what doctors know and how often they use these techniques. No treatments or procedures are tested—just a questionnaire.
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC